#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	13372	16S	1529	1529	100.0	16S.l6.c4.ctg.1	2069	641.6	1	SNP	n	C1184T	0	.	.	1184	1184	C	1416	1416	C	769	C	719	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	24170	23S	2890	2890	99.86	23S.l6.c4.ctg.1	3403	707.4	0	.	n	.	0	A20C	SNP	20	20	A	279	279	C	470	C,A	445,3	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	24170	23S	2890	2890	99.86	23S.l6.c4.ctg.1	3403	707.4	0	.	n	.	0	T695C	SNP	695	695	T	954	954	C	728	C,T	688,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	24170	23S	2890	2890	99.86	23S.l6.c4.ctg.1	3403	707.4	0	.	n	.	0	A1638G	SNP	1638	1638	A	1897	1897	G	838	G,A	790,2	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	24170	23S	2890	2890	99.86	23S.l6.c4.ctg.1	3403	707.4	0	.	n	.	0	T1971C	SNP	1971	1971	T	2230	2230	C	749	C	695	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	24170	23S	2890	2890	99.86	23S.l6.c4.ctg.1	3403	707.4	1	SNP	n	A2045G	0	.	.	2045	2045	A	2304	2304	A	783	A	744	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	24170	23S	2890	2890	99.86	23S.l6.c4.ctg.1	3403	707.4	1	SNP	n	C2597T	0	.	.	2597	2597	C	2856	2856	C	800	C	752	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_V_01427c	folP.WHO_V_01427c	1	1	27	1802	folP	855	855	100.0	folP.l15.c4.ctg.1	1454	123.3	1	SNP	p	R229S	1	.	.	685	687	AGC	981	983	AGC	181;183;183	A;G;C	170;171;171	folP.WHO_V_01427c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4910	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3412	143.5	1	SNP	p	S91F	1	.	.	271	273	TTC	602	604	TTC	138;138;140	T;T;C	133;131;133	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4910	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3412	143.5	1	SNP	p	D95G	1	.	.	283	285	GGC	614	616	GGC	147;147;147	G;G;C	138;137;136	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4910	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3412	143.5	1	SNP	p	G95N	0	.	.	283	285	GGC	614	616	GGC	147;147;147	G;G;C	138;137;136	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_O_01438	mtrR.WHO_O_01438	1	1	539	1566	mtrR	633	633	99.84	mtrR.l6.c4.ctg.1	1278	122.1	0	.	p	.	0	F184L	NONSYN	550	552	TTC	906	908	TTG	155;154;153	T;T;G	146;145;143	.	.
mtrR.WHO_O_01438	mtrR.WHO_O_01438	1	1	539	1566	mtrR	633	633	99.84	mtrR.l6.c4.ctg.1	1278	122.1	1	SNP	p	G45D	0	.	.	133	135	GGC	489	491	GGC	190;189;189	G;G;C	175;170;174	mtrR.WHO_O_01438:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	818	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	997	82.0	0	.	n	.	0	A197.	DEL	197	197	A	545	545	A	191	A	179	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4668	parC	2304	2304	100.0	parC.l15.c17.ctg.1	2956	157.4	1	SNP	p	D86N	0	.	.	256	258	GAC	539	541	GAC	162;159;158	G;A;C	153;146;152	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4668	parC	2304	2304	100.0	parC.l15.c17.ctg.1	2956	157.4	1	SNP	p	S87R	1	.	.	259	261	CGT	542	544	CGT	157;155;156	C;G;T	151;145;145	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4668	parC	2304	2304	100.0	parC.l15.c17.ctg.1	2956	157.4	1	SNP	p	R87W	0	.	.	259	261	CGT	542	544	CGT	157;155;156	C;G;T	151;145;145	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4668	parC	2304	2304	100.0	parC.l15.c17.ctg.1	2956	157.4	1	SNP	p	R87I	0	.	.	259	261	CGT	542	544	CGT	157;155;156	C;G;T	151;145;145	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4668	parC	2304	2304	100.0	parC.l15.c17.ctg.1	2956	157.4	1	SNP	p	S88P	0	.	.	262	264	TCC	545	547	TCC	157;157;158	T;C;C	151;151;154	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	3816	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2660	143.0	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1603	1605	GGC	186;185;186	G;G;C	175;175;174	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.5.002	penA.5.002	1	1	27	3584	penA	1752	1752	100.0	penA.l15.c30.ctg.1	2255	157.6	1	SNP	p	A311V	0	.	.	931	933	GCA	1120	1122	GCA	175;174;177	G;C;A	164;163;169	penA.5.002:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3584	penA	1752	1752	100.0	penA.l15.c30.ctg.1	2255	157.6	1	SNP	p	I312M	0	.	.	934	936	ATC	1123	1125	ATC	177;177;178	A;T;C	166;166;168	penA.5.002:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3584	penA	1752	1752	100.0	penA.l15.c30.ctg.1	2255	157.6	1	SNP	p	V316P	0	.	.	946	948	GTG	1135	1137	GTG	182;176;176	G;T;G	171;166;166	penA.5.002:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3584	penA	1752	1752	100.0	penA.l15.c30.ctg.1	2255	157.6	1	SNP	p	V316T	0	.	.	946	948	GTG	1135	1137	GTG	182;176;176	G;T;G	171;166;166	penA.5.002:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3584	penA	1752	1752	100.0	penA.l15.c30.ctg.1	2255	157.6	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1639	1641	ACC	161;161;163	A;C;C	151;154;153	penA.5.002:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3584	penA	1752	1752	100.0	penA.l15.c30.ctg.1	2255	157.6	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1693	1695	GCG	151;152;151	G;C;G,A	136;123;127,1	penA.5.002:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3584	penA	1752	1752	100.0	penA.l15.c30.ctg.1	2255	157.6	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1693	1695	GCG	151;152;151	G;C;G,A	136;123;127,1	penA.5.002:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3584	penA	1752	1752	100.0	penA.l15.c30.ctg.1	2255	157.6	1	SNP	p	G543S	1	.	.	1627	1629	AGC	1816	1818	AGC	154;152;152	A;G;C	143;143;143	penA.5.002:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3584	penA	1752	1752	100.0	penA.l15.c30.ctg.1	2255	157.6	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1825	1827	GGC	144;145;145	G;G;C	137;135;135	penA.5.002:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3584	penA	1752	1752	100.0	penA.l15.c30.ctg.1	2255	157.6	1	SNP	p	P552S	0	.	.	1654	1656	CCG	1843	1845	CCG	124;126;126	C,G;C,G;G	90,5;90,1;89	penA.5.002:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_F_00106	ponA.WHO_F_00106	1	1	27	5218	ponA	2397	2397	99.92	ponA.l6.c30.ctg.1	3036	171.4	1	SNP	p	L421P	0	.	.	1261	1263	CTG	1628	1630	CTG	208;210;210	C;T,C;G	191;190,1;191	ponA.WHO_F_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	1996	porA	1146	1146	99.83	porA.l15.c4.ctg.1	1827	108.7	0	.	p	.	0	M83fs	FSHIFT	247	247	A	598	598	C	157	C	147	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	320	porB1a	984	112	91.96	porB1a.l15.c30.ctg.1	386	38.7	0	.	p	.	0	M18T	NONSYN	52	54	ATG	270	272	ACG	80;79;78	A;C;G	69;69;68	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	320	porB1a	984	112	91.96	porB1a.l15.c30.ctg.1	386	38.7	0	.	p	.	0	E32Q	NONSYN	94	96	GAA	312	314	CAA	32;29;28	C;A;A	30;27;26	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	320	porB1a	984	112	91.96	porB1a.l15.c30.ctg.1	386	38.7	0	.	p	.	0	S34Y	NONSYN	100	102	TCC	318	320	TAC	20;18;15	T;A;C	19;18;15	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2576	porB1b	1047	1047	99.24	porB1b.l15.c17.ctg.1	1455	176.1	0	.	p	.	0	N38E	NONSYN	112	114	AAT	380	382	GAA	225;228;224	G;A;A	207;212;207	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2576	porB1b	1047	1047	99.24	porB1b.l15.c17.ctg.1	1455	176.1	0	.	p	.	0	P175S	NONSYN	523	525	CCA	791	793	TCA	218;219;222	T;C;A	199;197;205	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2576	porB1b	1047	1047	99.24	porB1b.l15.c17.ctg.1	1455	176.1	0	.	p	.	0	A218V	NONSYN	652	654	GCC	920	922	GTC	212;212;212	G;T;C	200;200;201	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2576	porB1b	1047	1047	99.24	porB1b.l15.c17.ctg.1	1455	176.1	0	.	p	.	0	F222S	NONSYN	664	666	TTT	932	934	TCT	210;216;218	T;C,T;T	200;206,1;209	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2576	porB1b	1047	1047	99.24	porB1b.l15.c17.ctg.1	1455	176.1	0	.	p	.	0	E328A	NONSYN	982	984	GAA	1250	1252	GCA	180;178;180	G;C;A	171;168;170	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2576	porB1b	1047	1047	99.24	porB1b.l15.c17.ctg.1	1455	176.1	1	SNP	p	G120K	1	.	.	358	360	AAG	626	628	AAG	221;221;220	A;A;G,C	209;209;207,1	porB1b.WHO_V_02265c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2576	porB1b	1047	1047	99.24	porB1b.l15.c17.ctg.1	1455	176.1	1	SNP	p	D121N	0	.	.	361	363	GAC	629	631	GAC	220;223;223	G,A;A;C	207,1;210;211	porB1b.WHO_V_02265c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2576	porB1b	1047	1047	99.24	porB1b.l15.c17.ctg.1	1455	176.1	1	SNP	p	A121D	1	.	.	361	363	GAC	629	631	GAC	220;223;223	G,A;A;C	207,1;210;211	porB1b.WHO_V_02265c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	9582	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	4781	199.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1056	rpsJ	312	312	100.0	rpsJ.l15.c30.ctg.1	1024	102.7	1	SNP	p	V57M	1	.	.	169	171	ATG	550	552	ATG	203;203;204	A;T;G	194;195;194	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
